Private EquityScreenerRefer

MARKET INSIGHTS

  • EventsNEWPrivate market milestones
  • NewsPrecize daily pulse
  • BlogsIn-depth articles and opinions

GUIDES

Explore Now
  • Unlisted SharesStep-by-step · KYC
  • BuyingStep-by-step · KYC
  • SellingExit in 24 - 48 hours
  • Pre-IPOReturns · risks · case studies
  • Tax GuideBudget 2026 changes
  1. Home
  2. Unlisted share news
  3. S3V Vascular Technologies – Series B Funding from AM Naik, Madhusudan K…

S3V Vascular Technologies – Series B Funding from AM Naik, Madhusudan Kela & Others

14 Mar 2024

Add as preferred source
Key Takeaways

Key Takeaway:

  • S3V Vascular's high-caliber investor backing and focus on indigenizing high-end stroke-care devices position it as a significant healthcare import-substitution play, though scaling manufacturing, achieving regulatory clearances, and securing hospital adoption remain critical execution milestones.

Key Takeaway:

  • S3V Vascular's high-caliber investor backing and focus on indigenizing high-end stroke-care devices position it as a significant healthcare import-substitution play, though scaling manufacturing, achieving regulatory clearances, and securing hospital adoption remain critical execution milestones.

S3V Vascular Technologies

S3V Vascular Technologies

0.00%

Expert Analysis

Expert Analysis:

  • S3V Vascular has secured Series B funding from prominent investors including L&T Chairman Emeritus A.M. Naik, Madhusudan Kela, Utpal Sheth (Rare Enterprises), and other ultra-high net worth individuals, reflecting strong institutional and investor confidence in the medical device import-substitution opportunity.​

  • The company is establishing an integrated manufacturing facility to produce neurovascular devices including stent retrievers, microcatheters, and guidewires for India's stroke care market, with plans to scale production capacity significantly.​

  • S3V's strategy includes pursuing international regulatory approvals (USFDA, CE certifications) to enable exports to Asia, Latin America, and Europe, and partnering with hospitals and public health systems including Ayushman Bharat to improve access to affordable thrombectomy procedures across India.​

Publisher:The Economic Times